Insider Transactions in Q1 2024 at Vyne Therapeutics Inc. (VYNE)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 02
2024
|
Mutya Harsch CHIEF LEGAL OFFICER AND GC |
SELL
Payment of exercise price or tax liability
|
Direct |
161
-0.11%
|
$322
$2.28 P/Share
|
|
Jan 02
2024
|
Iain Stuart CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
157
-0.12%
|
$314
$2.28 P/Share
|
|
Jan 02
2024
|
Tyler Zeronda CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
93
-0.07%
|
$186
$2.28 P/Share
|
|
Jan 02
2024
|
David Domzalski PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,004
-0.2%
|
$2,008
$2.28 P/Share
|
|
Jan 01
2024
|
Mutya Harsch CHIEF LEGAL OFFICER AND GC |
BUY
Grant, award, or other acquisition
|
Direct |
62,500
+29.47%
|
-
|
|
Jan 01
2024
|
Iain Stuart CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
62,500
+31.8%
|
-
|
|
Jan 01
2024
|
Tyler Zeronda CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
62,500
+32.15%
|
-
|
|
Jan 01
2024
|
David Domzalski PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
225,000
+31.2%
|
-
|